MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 10.02.2026
Sonoma Pharmaceuticals Kurzfristige Verbindlichkeiten 2011-2026 | SNOA
Kurzfristige Verbindlichkeiten Jährlich Sonoma Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.1 M | 3.72 M | 3.72 M | 5.82 M | 4.08 M | 4.86 M | 3.59 M | 3.26 M | 3.29 M | 3.55 M | 2.58 M | 7.57 M | 5.13 M | 4.75 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.57 M | 2.58 M | 4.29 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Arzneimittelhersteller
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
125 M | - | - | $ 754 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
2.65 M | - | 7.5 % | $ 6.35 M | USA |
 |
Catalent
CTLT
|
1.03 B | - | - | $ 11.5 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
11.4 M | - | 0.86 % | $ 117 M | USA |
 |
DURECT Corporation
DRRX
|
27 M | - | - | $ 50.1 M | USA |
 |
Canopy Growth Corporation
CGC
|
94.4 M | $ 1.1 | 3.77 % | $ 118 M |  Canada |
 |
Endo International plc
ENDP
|
539 M | - | - | $ 28.9 M |  Irlanda |
 |
Agile Therapeutics
AGRX
|
20.8 M | - | 10.11 % | $ 58.2 M | USA |
 |
Evoke Pharma
EVOK
|
9.65 M | - | - | $ 36.6 M | USA |
 |
Alimera Sciences
ALIM
|
21.9 M | - | - | $ 142 M | USA |
 |
Evolus
EOLS
|
75.3 M | $ 5.46 | 32.2 % | $ 352 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
48.8 M | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
9.4 M | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
5.02 M | $ 0.57 | 3.55 % | $ 9.95 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
31.6 M | $ 4.58 | - | $ 64.4 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
23 M | - | - | $ 193 M | Canada |
 |
Athenex
ATNX
|
115 M | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
96.3 M | $ 39.84 | 3.2 % | $ 1.46 B | USA |
 |
Emergent BioSolutions
EBS
|
651 M | $ 8.88 | -0.34 % | $ 455 M | USA |
 |
ProPhase Labs
PRPH
|
16.1 M | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
93.4 M | $ 11.86 | -0.29 % | $ 842 M | USA |
 |
Radius Health
RDUS
|
94.8 M | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
4.3 B | $ 5.63 | -1.66 % | $ 2.05 B | Canada |
 |
Lannett Company
LCI
|
105 M | - | 1.15 % | $ 7.11 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
111 M | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
77.5 M | $ 2.89 | 0.7 % | $ 381 M | USA |
 |
Rockwell Medical
RMTI
|
16.6 M | $ 0.89 | -1.05 % | $ 20.8 M | USA |
 |
Perrigo Company plc
PRGO
|
1.01 B | $ 11.57 | 1.62 % | $ 1.6 B | USA |
 |
Veru
VERU
|
11.9 M | $ 2.56 | 1.39 % | $ 345 M | USA |
 |
Viatris
VTRS
|
6.75 B | $ 14.89 | -0.03 % | $ 17.9 B | USA |
 |
cbdMD
YCBD
|
8.62 M | $ 0.76 | -2.68 % | $ 3.28 M | USA |
 |
TherapeuticsMD
TXMD
|
6.85 M | $ 2.3 | 3.57 % | $ 24 M | USA |
 |
Pacira BioSciences
PCRX
|
310 M | $ 22.11 | 0.05 % | $ 1.02 B | USA |
 |
PetIQ
PETQ
|
190 M | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
177 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
11.9 M | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
50 M | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
12.2 M | $ 4.66 | -0.32 % | $ 140 M | USA |
 |
SCYNEXIS
SCYX
|
16.3 M | $ 0.75 | -0.27 % | $ 35.9 M | USA |
 |
Solid Biosciences
SLDB
|
30.3 M | $ 5.96 | 0.02 % | $ 243 M | USA |
 |
Tricida
TCDA
|
29.5 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
433 M | $ 7.53 | 2.31 % | $ 4.65 B | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
9.17 M | - | - | $ 55.5 M | USA |